Frazier Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Frazier Financial Advisors's BMY Position: Q3 2026 in Review
Frazier Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q3 2026, buying an estimated $1.39K and bringing the position to 905 shares worth $56.5K. The position accounts for 0.03% of the portfolio, ranked #188.
Frazier Financial Advisors first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Frazier Financial Advisors held 905 shares of Bristol-Myers Squibb worth $56.5K as of Q3 2026.
- Frazier Financial Advisors bought 22 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.39K.
- Bristol-Myers Squibb made up 0.03% of Frazier Financial Advisors's portfolio in Q3 2026, its #188 holding.
- Frazier Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.